Maternal serum placental protein 13 at eleven to thirteen weeks in chromosomally abnormal pregnancies

Fetal Diagnosis and Therapy

Volumn 27, Issue 2, 2010, Pages 72-77

  Akolekar, Ranjit ^a   Pérez Penco, José María ^a,b   Skyfta, Evdoxia ^a,b   Rodríguez Calvo, Jesús ^a,b   Nicolaides, Kypros H ^a,b  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

Author keywords

First trimester screening; Free human chorionic gonadotropin; Placental protein 13; Pregnancy associated plasma protein A; Trisomy 18; Trisomy 21

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT; PLACENTA PROTEIN; PLACENTAL PROTEIN 13; PREGNANCY ASSOCIATED PLASMA PROTEIN A; UNCLASSIFIED DRUG;

ADULT; ANEUPLOIDY; ARTICLE; CHROMOSOME ABERRATION; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRIPLOIDY; TRISOMY 18; TRISOMY 21; TURNER SYNDROME;

ADULT; ANEUPLOIDY; CASE-CONTROL STUDIES; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 13; CHROMOSOMES, HUMAN, PAIR 18; DOWN SYNDROME; FEMALE; GALECTINS; GESTATIONAL AGE; HUMANS; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY; PREGNANCY PROTEINS; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PRENATAL DIAGNOSIS; TRISOMY; TURNER SYNDROME;

EID: 77950151429     PISSN: 10153837     EISSN: None     Source Type: Journal    
DOI: 10.1159/000294340     Document Type: Article

References (31)

1. Burger O, Pick E, Zwickel J, Klayman M, Meiri H, Slotky R, Mandel S, Rabinovitch L, Paltieli Y, Admon A, Gonen R: Placental protein 13 (PP-13): effects on cultured trophoblasts, and its detection in human body fluids in normal and pathological pregnancies. Placenta 2004; 25: 608-622.
2. Than NG, Sumegi B, Than GN, Berente Z, Bohn H: Isolation and sequence analysis of a cDNA encoding human placental tissue protein 13 (PP13), a new lysophospholipase, homologue of human eosinophil Charcot-Leyden crystal protein. Placenta 1999; 20: 703-710.
3. Than NG, Pick E, Bellyei S, Szigeti A, Burger O, Berente Z, Janaky T, Boronkai A, Kliman H, Meiri H, Bohn H, Than GN, Sumegi B: Functional analyses of placental protein 13/ galectin-13. Eur J Biochem 2004; 271: 1065-1078.
4. Akolekar R, Syngelaki A, Beta J, Kocylowski R, Nicolaides KH: Maternal serum placental protein 13 (PP13) at 11-13 weeks of gestation in preeclampsia. Prenat Diagn 2009; 29: 1103-1108.
5. Chafetz I, Kuhnreich I, Sammar M, Tal Y, Gibor Y, Meiri H, Cuckle H, Wolf M: First-trimester placental protein 13 screening for preeclampsia and intrauterine growth restriction. Am J Obstet Gynecol 2007; 197: 35. e1-35. e7.
6. Khalil A, Cowans NJ, Spencer K, Goichman S, Meiri H, Harrington K: First-trimester maternal serum placental protein 13 for the prediction of pre-eclampsia in women with a priori high risk. Prenat Diagn 2009; 29: 781-789.
7. Nicolaides KH, Bindra R, Turan OM, Chefetz I, Sammar M, Meiri H, Tal J, Cuckle HS: A novel approach to first-trimester screening for early pre-eclampsia combining serum PP-13 and Doppler ultrasound. Ultrasound Obstet Gynecol 2006; 27: 13-17.
8. Spencer K, Cowans NJ, Chefetz I, Tal J, Meiri H: First-trimester maternal serum PP-13, PAPP-A and second-trimester uterine artery Doppler pulsatility index as markers of preeclampsia. Ultrasound Obstet Gynecol 2007; 29: 128-134.
9. Jauniaux E, Hustin J: Chromosomally abnormal early ongoing pregnancies: correlation of ultrasound and placental histological findings. Hum Pathol 1998; 29: 1195-1199.
10. Frendo JL, Vidaud M, Guibourdenche J, Luton D, Muller F, Bellet D, Giovagrandi Y, Tarrade A, Porquet D, Blot P, Evain-Brion D: Defect of villous cytotrophoblast differentiation into syncytiotrophoblast in Down's syndrome. J Clin Endocrinol Metab 2000; 85: 3700-3707.
11. Roberts L, Sebire NJ, Fowler D, Nicolaides KH: Histomorphological features of chorionic villi at 10-14 weeks of gestation in trisomic and chromosomally normal pregnancies. Placenta 2000; 21: 678-683.
12. Kagan KO, Wright D, Baker A, Sahota D, Nicolaides KH: Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta-human chorionic gonadotropin, and pregnancy-associated plasma protein A. Ultrasound Obstet Gynecol 2008; 31: 618-624.
13. Kagan KO, Wright D, Valencia C, Maiz N, Nicolaides KH: Screening for trisomies 21, 18 and 13 by maternal age, fetal nuchal translucency, fetal heart rate, free beta-hCG and pregnancy-associated plasma protein A. Hum Reprod 2008; 23: 1968-1975.
14. Snijders RJ, Noble P, Sebire N, Souka A, Nicolaides KH: UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal translucency thickness at 10-14 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group. Lancet 1998; 352: 343-346.
15. Kagan KO, Wright D, Spencer K, Molina FS, Nicolaides KH: First-trimester screening for trisomy 21 by free beta-human chorionic gonadotropin and pregnancy-associated plasma protein A: impact of maternal and pregnancy characteristics. Ultrasound Obstet Gynecol 2008; 31: 493-502.
16. Wright D, Kagan KO, Molina FS, Gazzoni A, Nicolaides KH: A mixture model of nuchal translucency thickness in screening for chromosomal defects. Ultrasound Obstet Gynecol 2008; 31: 376-383.
17. Sabet LM, Daya D, Stead R, Richmond H, Jimeneze CL: Significance and value of immunohistochemical localization of pregnancy- specific proteins in feto-maternal tissue throughout pregnancy. Mod Pathol 1989; 2: 227-232.
18. Gaspard UJ, Hustin J, Reuter AM, Lambotte R, Franchimont P: Immunofluorescent localization of placental lactogen, chorionic gonadotrophin and its alpha and beta subunits in organ cultures of human placenta. Placenta 1980; 1: 135-144.
19. Dobashi K, Ajika K, Ohkawa T, Okano H, Okinaga S, Arai K: Immunohistochemical localization of pregnancy-associated plasma protein A (PAPP-A) in placentae from normal and pre-eclamptic pregnancies. Placenta 1984; 5: 205-212.
20. Koster MP, Wortelboer EJ, Cuckle HS, Stoutenbeek P, Visser GH, Schielen PC: Placental protein 13 as a first-trimester screening marker for aneuploidy. Prenat Diagn 2009; 29: 1237-1241.
21. Cowans NJ, Spencer K, Meiri H: First-trimester maternal placental protein 13 levels in pregnancies resulting in adverse outcomes. Prenat Diagn 2008; 28: 121-125.
22. Huppertz B, Sammar M, Chefetz I, Neumaier- Wagner P, Bartz C, Meiri H: Longitudinal determination of serum placental protein 13 during development of preeclampsia. Fetal Diagn Ther 2008; 24: 230-236.
23. Nicolaides KH, Spencer K, Avgidou K, Faiola S, Falcon O: Multicenter study of first-trimester screening for trisomy 21 in 75,821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening. Ultrasound Obstet Gynecol 2005; 25: 221-226.
24. Snijders RJM, Holzgreve W, Cuckle H, Nicolaides KH: Maternal age-specific risks for trisomies at 9-14 weeks' gestation. Prenat Diagn 1994; 14: 543-552.
25. Snijders RJM, Sebire NJ, Nicolaides KH: Maternal age and gestational age-specific risks for chromosomal defects. Fetal Diagn Ther 1995; 10: 356-367.
26. Snijders RJM, Sundberg K, Holzgreve W, Henry G, Nicolaides KH: Maternal age and gestation-specific risk for trisomy 21. Ultrasound Obstet Gynecol 1999; 13: 167-170.
27. Tul N, Spencer K, Noble P, Chan C, Nicolaides KH: Screening for trisomy 18 by fetal nuchal translucency and maternal serum free beta-hCG and PAPP-A at 10-14 weeks of gestation. Prenat Diagn 1999; 19: 1035-1042.
28. Spencer K, Ong C, Skentou H, Liao AW, Nicolaides KH: Screening for trisomy 13 by fetal nuchal translucency and maternal serum free beta-hCG and PAPP-A at 10-14 weeks of gestation. Prenat Diagn 2000; 20: 411-416.
29. Hyett JA, Noble PL, Snijders RJM, Montenegro N, Nicolaides KH: Fetal heart rate in trisomy 21 and other chromosomal abnormalities at 10-14 weeks of gestation. Ultrasound Obstet Gynecol 1996; 7: 239-244.
30. Liao AW, Snijders RJM, Geerts L, Spencer K, Nicolaides KH: Fetal heart rate in chromosomally abnormal fetuses. Ultrasound Obstet Gynecol 2000; 16: 610-613.
31. Papageorghiou AT, Avgidou K, Spencer K, Nix B, Nicolaides KH: Sonographic screening for trisomy 13 at 11 to 13+6 weeks of gestation. Am J Obstet Gynecol 2006; 194: 397-401.